Martingale Asset Management L P Ventyx Biosciences, Inc. Transaction History

Martingale Asset Management L P

  • $4.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$29.8 - $40.3 $286,825 - $387,887
9,625 Added 60.16%
25,625 $889,000
Q2 2023

Aug 11, 2023
BUY
$28.53 - $39.55 $8,216 - $11,390
288 Added 1.83%
16,000 $524,000
Q1 2023

May 12, 2023
BUY
$29.51 - $46.65 $463,661 - $732,964
15,712 New
15,712 $526,000

Others Institutions Holding VTYX

# of Institutions
125
Shares Held
52.9M
Call Options Held
35.3K
Put Options Held
83K
View Full List

About Ventyx Biosciences, Inc.

VTYX Quotes by TradingView
  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $127M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email